Andrew Napper, based in Princeton, NJ, US, is currently a Executive Director, Head of Automation and Assay Technologies at Bristol Myers Squibb, bringing experience from previous roles at Evotec, SLAS (Society for Laboratory Automation and Screening), FLX Bio, Inc. and ASSAY and Drug Development Technologies. Andrew Napper holds a 1984 - 1989 Ph.D. in Chemistry @ Penn State University. With a robust skill set that includes Life Sciences, Drug Discovery, Cell Based Assays, High Throughput Screening, HTS and more, Andrew Napper contributes valuable insights to the industry. Andrew Napper has 3 emails and 1 mobile phone number on RocketReach.